HSBC Holdings’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $976K | Buy |
53,415
+41,059
| +332% | +$750K | ﹤0.01% | 1405 |
|
|
2025
Q1 | $219K | Sell |
12,356
-37,369
| -75% | -$662K | ﹤0.01% | 2130 |
|
|
2024
Q4 | $1.5M | Sell |
49,725
-9,069
| -15% | -$273K | ﹤0.01% | 1270 |
|
|
2024
Q3 | $910K | Sell |
58,794
-15,024
| -20% | -$233K | ﹤0.01% | 1410 |
|
|
2024
Q2 | $1.26M | Sell |
73,818
-75,530
| -51% | -$1.29M | ﹤0.01% | 1282 |
|
|
2024
Q1 | $2.33M | Buy |
149,348
+48,889
| +49% | +$764K | ﹤0.01% | 1122 |
|
|
2023
Q4 | $1.48M | Buy |
100,459
+64,244
| +177% | +$950K | ﹤0.01% | 1266 |
|
|
2023
Q3 | $592K | Buy |
36,215
+9,982
| +38% | +$163K | ﹤0.01% | 1485 |
|
|
2023
Q2 | $1.09M | Sell |
26,233
-302
| -1% | -$12.6K | ﹤0.01% | 1326 |
|
|
2023
Q1 | $1.6M | Buy |
26,535
+22,156
| +506% | +$1.33M | ﹤0.01% | 1263 |
|
|
2022
Q4 | $313K | Sell |
4,379
-14,013
| -76% | -$1M | ﹤0.01% | 2065 |
|
|
2022
Q3 | $1.43M | Buy |
18,392
+2,825
| +18% | +$220K | ﹤0.01% | 1347 |
|
|
2022
Q2 | $1.1M | Buy |
+15,567
| New | +$1.1M | ﹤0.01% | 1548 |
|
|
2021
Q3 | – | Sell |
-6,046
| Closed | -$1.34M | – | 2607 |
|
|
2021
Q2 | $1.34M | Buy |
6,046
+3,443
| +132% | +$764K | ﹤0.01% | 1291 |
|
|
2021
Q1 | $346K | Sell |
2,603
-1,160
| -31% | -$154K | ﹤0.01% | 1863 |
|
|
2020
Q4 | $651K | Buy |
3,763
+1,015
| +37% | +$176K | ﹤0.01% | 1607 |
|
|
2020
Q3 | $309K | Buy |
+2,748
| New | +$309K | ﹤0.01% | 1825 |
|
|
2019
Q3 | – | Sell |
-7,551
| Closed | -$477K | – | 2477 |
|
|
2019
Q2 | $477K | Buy |
7,551
+2,549
| +51% | +$161K | ﹤0.01% | 1543 |
|
|
2019
Q1 | $241K | Buy |
+5,002
| New | +$241K | ﹤0.01% | 1933 |
|